Cara Partners manufacture a standardised extract of Ginkgo Biloba, an active pharmaceutical ingredient (API), at their Little Island plant. Cara Partners is a joint venture between the Ipsen Group of France and the Schwabe Group of Germany. The parent companies discovered, through clinical trials, that the extract of Ginkgo Biloba had significant pharmacological activity and, in 1978, they decided to produce the extract on a production scale in Cork.
Eli Lilly and Company has been in business for over 140 years. Lilly unites caring with discovery to make life better for people around the world. They focus on five core global business areas: bio-medicines, diabetes, oncology, emerging markets and animal health. They also continue to pursue innovative science and new opportunities beyond the targeted disease categories.